Breast Care Quality Metrics

Commission on Cancer's Quality of Care Measures

UC San Diego Health's cancer program is accredited by the Commission on Cancer (CoC), which collects standardized data from CoC-accredited health care settings to measure cancer care quality. The data presented below is included in the CoC's quality of care measures for breast cancer, and are for 2012, the most recent year for which data is available. (Data provided by the National Cancer Database.)  

The purpose of the data is to compare the care of breast cancer patients at UC San Diego Health with other CoC-accredited cancer programs regionally and nationwide. UC San Diego's results compare favorably in all below meaures. For more information about quality and safety measures, see Quality Care.

Combination chemotherapy considered within four months of diagnosis (when appropriate) - diagnosis year 2012

UC San Diego Health 100%
State of California 86.4%
Pacific Region 89.8%
Teaching Hospitals 89.7%
All Commission on Cancer Approved Programs 91.5%

Administration of hormone therapy considered within one year of diagnosis (when appropriate) - diagnosis year 2012

UC San Diego Health 97.4%
State of California 85.1%
Pacific Region 88.2%
Teaching Hospitals 89.2%
All Commission on Cancer Approved Programs 89.7%